The genotype of the LQTS influences the clinical course, with a higher risk of cardiac events observed in individuals with mutations at the LQT1 or LQT2 locus compared to those with mutations at the LQT3 locus [4]. This evidence concerns the gene KCNH2 and familial long QT syndrome.